---

South Florida Cardiac Amyloid Symposium
Wake up and Look Around
Towards Early Recognition, Diagnosis and Treatment of Cardiac Amyloidosis

Register Now
Registration Rates: Members—$149, Nonmembers—$199

March 21, 2020
7:45 am - 1:00 pm

---

Cardiac Amyloidosis: From Missed and Undiagnosed, to Common and Treatable 
April 4, 2020
8:00 am - 12:00 pm

Houston Methodist Hospital
6565 Fannin Street
Houston, TX 77030

 

Program Director: Mouaz Al-Mallah, MD, FASNC

3.25* CME credits available
4.5* ARRT Category A CE credits available for technologists 
*Credits subject to change
 

Agenda

Time Title Speaker 8:00am - 8:30am  Registration   8:30am - 8:35am  Welcome Mouaz Al-Mallah, MD 8:35am - 9:00am  ATTR Cardiac Amyloidosis: Clinical Presentation and Outcomes Juan C. Lopez-Mattei, MD 9:00am - 9:20am  The Role of Echocardiography and Cardiac MRI in Suspected Cardiac Amyloidosis Faisal Nabi, MD 9:20am - 9:45am  PYP Imaging: Diagnostic Accuracy and Pitfalls John Mahmarian, MD 9:45am - 10:00am  Cardiac PET in Suspected Cardiac Amyloidosis Mouaz Al-Mallah, MD 10:00am - 10:20am  Management of ATTR Amyloidosis Barry Trachtenberg, MD 10:20am - 10:40am  Panel Discussion   10:40am - 11:00am  Break   11:00am - 11:45am  Case Presentations Mohammad Chamsi Pasha, DO Ali Agha, MD Alpana Senapati, DO Moderator: Mouaz Al-Mallah, MD   Panel: Faisal Nabi, MD Mahwash Kassi, MD John Mahmarian, MD Barry Trachtenberg, MD 11:45am - Noon  Final Remarks Mouaz Al-Mallah, MD

 
This program is jointly sponsored by the American Society of Nuclear Cardiology and Houston Methodist.

---

Cardiac Amyloidosis: A Practical Primer

Register Now

April 17, 2020
8:00 am - 12:00 pm

The Ritz-Carlton, Tysons Corner
1700 Tysons Blvd, McLean VA 22102

4* CME credits available
*Credits subject to change

Included with Nuclear Cardiology Today registration. Please indicate on the NC Today registration page if you are interested in attending.

Workshop Only Registration: If you prefer to attend the workshop only, the registration fee for the standalone program is $99.

Agenda

Time Title Speaker 8:00 am Opening Remarks and Introduction James Udelson, MD   Part I: The Basics   8:05 am The Disease and the Work-up Prem Soman, MD, PhD 8:35 am The Imaging Sharmila Dorbala, MD, MPH 9:05 am The Treatment Frederick Ruberg, MD 9:35 am Q&A Panel       9:45 am Break     Part II: Imaging Nuts and Bolts   10:00 am Practical Aspects of Acquiring and Interpreting Tc-99m PYP Imaging: An Interactive Workshop Prem Soman, MD, PhD, Joseph Dietz, CNMT, Panel   Part III: Putting It All Together   11:00 am Deconstructing Diagnosis and Management: A Case-Based Discussion Prem Soman, MD, PhD, James Udelson, MD and Panel 11:45 am Q&A Panel Noon Closing Remarks Prem Soman, MD, PhD

---

The Cardiac Amyloidosis: On the Road programs will:

• Address the knowledge, competence and performance gaps in disease epidemiology, pathophysiology, diagnosis and treatments for ATTR-CM. 
• Improve diagnosis across all patient populations, timely referral to amyloid experts, and knowledge of treatment options with the goal of improving outcomes of patients with ATTR-CM. 
• Enhance the understanding of the overlap of cardiac amyloidosis with other conditions leading to a misdiagnosis or delayed diagnosis.  
• Focus on the diagnostic algorithm, including the appropriate use of Tc-99m PYP, and the importance of image interpretation alongside other clinical findings. 
• Discuss the central role of Tc-99m PYP imaging and the protocols for acquisition, processing and interpretation to ensure understanding of the procedure and the data it provides.
   

Participants of these programs will be able to:

• Describe amyloidosis, including specific types, cardiac features and disease burden.
• Identify barriers to identification and diagnosis of patients suspected of ATTR.
• Recognize patients at risk for hereditary ATTR (hATTR) and wild-type ATTR (wtATTR).
• Summarize the diagnostic evaluation for cardiac amyloidosis including the differential diagnosis. 
• Provide details of Tc-99m PYP including imaging protocol, semi-quantitative and quantitative scoring, interpretation including identifying false positive and false negative studies, and components of an appropriate report. 
• Demonstrate understanding of current treatments for patients with ATTR-CM.

If you have any questions about registration, please contact info@asnc.org

These programs are supported by educational grants from Pfizer.